$46.43
-0.45 (-0.96%)
Performance
1D
—
1W
—
1M
—
3M
-15.70%
6M
-24.71%
1Y
+13.55%
YTD
-13.65%
Open$46.18
Previous Close$46.88
Day High$46.96
Day Low$45.12
52W High$78.48
52W Low$30.04
Volume—
Avg Volume2.87M
Market Cap4.66B
P/E Ratio—
EPS$-6.51
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$54.19
Below
SMA 200
$54.12
Below
RSI (14)
52.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
35 analysts
Price Target
+139.2% upside
Current
$46.43
$46.43
Target
$111.08
$111.08
$83.97
$111.08 avg
$162.31
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.73M | 2.61M | 1.10B |
| Net Income | -618,566,079 | -389,280,100 | -133,819,624 |
| Profit Margin | -16,569.8% | -15,741.3% | -12.2% |
| EBITDA | -593,986,408 | -394,578,762 | -179,167,841 |
| Free Cash Flow | — | — | -115,939,335 |
| Rev Growth | +43.0% | +43.0% | +24.0% |
| Debt/Equity | — | — | 0.61 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |